‘Nucleated red blood cells’ as hypoxia marker in clinical analysis of blood in patients with coronavirus infection
https://doi.org/10.33667/2078-5631-2021-13-23-24
Abstract
Assessment of the condition of a patient with coronavirus infection is an urgent problem in clinical practice. The parameter ’nucleated erythrocytes’ in a clinical blood test can be used in clinical practice as a marker of hypoxia in case of lung damage, since it objectively reflects the consequences of acute hypoxic stress in the patient’s body.
About the Authors
O. Yu. DornRussian Federation
Dorn Olga Yu., PhD Med, assistant at Dept of Clinical Laboratory Diagnostics NSMU, doctor of Clinical Laboratory Diagnostics CCH No. 1.
Novosibirsk
F. M. Orifova
Russian Federation
Orifova Farzona M., doctor of clinical laboratory diagnostics.
Novosibirsk
E. G. Stepanova
Russian Federation
Stepanova Elena G., PhD Med, associate prof. at Dept of Clinical Laboratory Diagnostics.
Novosibirsk
References
1. Interim guidelines: prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 9 (10/26/20).
2. Olga Pozdnyakova, Nathan T. Connell, Elisabeth M. Battinelli, Jean M. Connors, Geoffrey Fell, and Annette S. Kim. Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection. J Clin Pathol 2020; XX: 1–11.
3. Vorobiev A.I. et al. Guide to Hematology. Volume 1. Edited by A.I. Vorobyov. 3rd ed., Rev. and add. M.: Medicine, 200. 448 p.
4. Mueller et al., Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients, Cell Reports Medicine (2020). https://doi.org/10.1016/j.xcrm.2020.100144
Review
For citations:
Dorn O.Yu., Orifova F.M., Stepanova E.G. ‘Nucleated red blood cells’ as hypoxia marker in clinical analysis of blood in patients with coronavirus infection. Medical alphabet. 2021;(13):23-24. (In Russ.) https://doi.org/10.33667/2078-5631-2021-13-23-24